aClinical benefit with FOLFOX (folinic acid, fluorouracil, oxaliplatin) systemic therapy for 24 weeks with 98% maximal serum CA19-9 reduction and partial metabolic response by EORTC PET criteria.bTran
aClinical benefit with FOLFOX (folinic acid, fluorouracil, oxaliplatin) systemic therapy for 24 weeks with 98% maximal serum CA19-9 reduction and partial metabolic response by EORTC PET criteria. bTra
Although children and adolescents with acute lymphoblastic leukaemia (ALL) have high survival rates, approximately 15-20% of patients relapse. Risk of relapse is routinely estimated at diagnosis by bi
Endometriosis is a chronic inflammatory gynaecological condition frequently associated with chronic pelvic pain. Visceral hypersensitivity could be present, like in other chronic pain conditions, caus
